Opus Point Partners Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$259K Hold
4,082
0.47% 48
2019
Q2
$276K Buy
4,082
+415
+11% +$27.3K 0.41% 55
2019
Q1
$238K Sell
3,667
-951
-21% -$63.2K 0.32% 70
2018
Q4
$289K Buy
4,618
+85
+2% +$5.94K 0.64% 29
2018
Q3
$350K Buy
4,533
+282
+7% +$21.3K 0.84% 41
2018
Q2
$301K Buy
4,251
+584
+16% +$41.2K 0.65% 35
2018
Q1
$276K Buy
3,667
+592
+19% +$47.1K 0.54% 43
2017
Q4
$220K Sell
3,075
-3,387
-52% -$257K 0.19% 58
2017
Q3
$524K Buy
6,462
+3,206
+98% +$245K 0.47% 47
2017
Q2
$230K Sell
3,256
-2,481
-43% -$165K 0.21% 59
2017
Q1
$390K Buy
5,737
+2,329
+68% +$164K 0.29% 54
2016
Q4
$244K Buy
+3,408
New +$253K 0.19% 49
2016
Q2
Sell
-3,282
Closed -$301K 47
2016
Q1
$301K Sell
3,282
-30,418
-90% -$2.74M 0.23% 52
2015
Q4
$3.41M Buy
33,700
+29,377
+680% +$3.06M 2.25% 19
2015
Q3
$424K Buy
4,323
+89
+2% +$9.88K 0.23% 45
2015
Q2
$496K Buy
4,234
+583
+16% +$63.7K 0.39% 49
2015
Q1
$358K Sell
3,651
-677
-16% -$68.7K 0.3% 62
2014
Q4
$408K Buy
+4,328
New +$448K 0.4% 51

Other funds holding GILD

Opus Point Partners Management's GILD Position: Q3 2019 in Review

Opus Point Partners Management held its Gilead Sciences (GILD) position steady in Q3 2019 at 4,082 shares worth $259K. The position accounts for 0.47% of the portfolio, ranked #48.

Opus Point Partners Management first reported a position in GILD in Q4 2014 and has held it in 18 quarters since. The position peaked at $3.41M in Q4 2015. 1,463 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • Opus Point Partners Management held 4,082 shares of Gilead Sciences worth $259K as of Q3 2019.
  • Opus Point Partners Management left its Gilead Sciences share count unchanged in Q3 2019.
  • Gilead Sciences made up 0.47% of Opus Point Partners Management's portfolio in Q3 2019, its #48 holding.
  • Opus Point Partners Management first reported a position in Gilead Sciences in Q4 2014 and has held it in 18 quarters since.
  • Opus Point Partners Management's Gilead Sciences position peaked at $3.41M in Q4 2015.
  • 1,463 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.